1. Home
  2. ONMD vs CRIS Comparison

ONMD vs CRIS Comparison

Compare ONMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$0.56

Market Cap

56.0M

Sector

N/A

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.43

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
CRIS
Founded
2006
2000
Country
United States
United States
Employees
23
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.0M
20.6M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ONMD
CRIS
Price
$0.56
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
256.3K
189.6K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.57
EPS
N/A
N/A
Revenue
N/A
$9,898,000.00
Revenue This Year
N/A
$27.10
Revenue Next Year
N/A
$67.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.50
52 Week Low
$0.33
$0.41
52 Week High
$4.22
$2.57

Technical Indicators

Market Signals
Indicator
ONMD
CRIS
Relative Strength Index (RSI) 25.19 29.32
Support Level N/A N/A
Resistance Level $0.96 $0.57
Average True Range (ATR) 0.06 0.04
MACD -0.02 -0.01
Stochastic Oscillator 1.78 2.27

Price Performance

Historical Comparison
ONMD
CRIS

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: